Journal of Antimicrobial Chemotherapy (1987) 20, 645-656
© 1987 The British Society for Antimicrobial Chemotherapy
research-article |
Ampicillin resistance in Haemophilus influenzae: identification of resistance mechanisms



Bacteriology Department, The Medical School, University of Edinburgh Teviot Place, Edinburgh EH8 9AG aChemotherapy Department, Microbiology Division, Glaxo Group Research Ltd Greenford Road, Greenford, UB6 OHE, U.K.
accepted 28 May 1987
Corresponding authorThe incidence and mechanisms of ampicillin resistance (MIC > 1 mg/l) were investigated in 105 clinical isolates of Haemophilus influenzae collected in Edinburgh during 1983/4. Fifteen (14.3%) ampicillin-resistant strains were identified and these were non-serotypable and comprised six biotypes. Isoelectric focusing and ß-lactamase-inhibition studies demonstrated that production of the TEM-1 ß-lactamase was the principal mechanism of resistance in nine (60%) strains. Radiolabelling revealed that one ß-lactamase-positive strain also had an unusual penicillin-binding protein (PBP) profit. No ß-lactamase activity was detected in the other six (40%) ampicillin-resistant strains. Two ß-lactamase-negative ampicillin-resistant strains had atypical PBP profiles. SDS-PAGE analysis showed that four ß-lactamase-negative ampicillin-resistant strains, including one with altered PBPs, exhibited outer membrane protein profiles which differed from those of sensitive strains of the same biotype. The ampicillin-resistance mechanism of the remaining strain could not be determined. Thus, several resistance mechanisms, either acting individually or in combination, are implicated in ampicillin resistance in H. influenzae.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Hotomi, K. Fujihara, D. S. Billal, K. Suzuki, T. Nishimura, S. Baba, and N. Yamanaka Genetic Characteristics and Clonal Dissemination of {beta}-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae Strains Isolated from the Upper Respiratory Tract of Patients in Japan Antimicrob. Agents Chemother., November 1, 2007; 51(11): 3969 - 3976. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bronner, D. Pompei, H. Elkhaili, N. Dhoyen, H. Monteil, and F. Jehl Ex vivo 12 h bactericidal activity of oral co-amoxiclav (1.125 g) against {beta}-lactamase-producing Haemophilus influenzae J. Antimicrob. Chemother., October 1, 2001; 48(4): 501 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gazagne, C. Delmas, E. Bingen, and H. Dabernat Molecular Epidemiology of Ampicillin-Resistant Non-beta -Lactamase-Producing Haemophilus influenzae J. Clin. Microbiol., December 1, 1998; 36(12): 3629 - 3635. [Abstract] [Full Text] |
||||


